Join to View Full Profile
7400 Crestway RdSan Antonio, TX 78239
Phone+1 210-569-9800
Fax+1 210-646-5606
Dr. Denham is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Family Medicine, 1989 - 1992
Texas College of Osteopathic MedicineClass of 1989
William & MaryNo Degree, Radiation Biology, 1981 - 1983- Hampden-Sydney CollegeB.S., Biology, 1977 - 1981
Certifications & Licensure
TX State License 1990 - 2027
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification athenaClinicals, athenahealth, Inc., 2013-2017
- CMS Meaningful Use Stage 1 Certification athenaClinicals, athenahealth, Inc., 2013-2017
- CMS Meaningful Use Stage 1 Certification athenaClinicals EHR, athenahealth, Inc, 2013
Clinical Trials
- Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on Metformin Start of enrollment: 2008 Dec 01
- Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Jun 18
- Clinical Trial for Evaluation of Vermillion's Blood Test to Predict the Probability of Peripheral Artery Disease Start of enrollment: 2011 Mar 01
Publications & Presentations
PubMed
- 2 citationsEvaluation of Accuracy and Safety of the 365-Day Implantable Eversense Continuous Glucose Monitoring System: The ENHANCE Study.Timothy S Bailey, David R Liljenquist, Douglas S Denham, Ronald L Brazg, Sorin Ioacara
Diabetes Technology & Therapeutics. 2025-05-01 - 2 citationsImmunogenicity, efficacy, and safety of biosimilar insulin glargine (Gan & Lee glargine) compared with originator insulin glargine (Lantus®) in patients with type 2 di...Elena A Christofides, Orlando Puente, Paul Norwood, Douglas Denham, Hiralal Maheshwari
Diabetes, Obesity & Metabolism. 2024-06-01 - Publisher Correction: Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial.Jeremy Pettus, Schafer C Boeder, Mark P Christiansen, Douglas S Denham, Timothy S Bailey
Nature Medicine. 2023-11-01
Press Mentions
San Antonio Researchers Conducting Trial for Potential COVID-19 Nasal Spray VaccinationMay 6th, 2021
Clinical Trials of Texas Conducts Clinical Trial of Implantable Device for Type 1 DiabetesSeptember 15th, 2019- San Antonio’s Clinical Trials of Texas Enrolls Patients for a Pneumonia Vaccine Clinical TrialJuly 16th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
